Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin.
List, Alan F. MD 1; Sun, Zhuoxin PhD 2; Verma, Amit MD 3,; Bennett, John M. MD 4; Komrokji, Rami S. MD 1; McGraw, Kathy PhD 1; Maciejewski, Jaroslaw MD, PhD 5; Altman, Jessica K. MD 6; Cheema, Puneet S. MD 7; Claxton, David F. MD 8; Luger, Selina M. MD 9; Mattison, Ryan J. MD 10; Wassenaar, Timothy R. MD 11; Artz, Andrew S. MD 12; Schiffer, Charles A. MD 13; Litzow, Mark R. MD 14; Tallman, Martin S. MD 15
[Report] Journal of Clinical Oncology. 39(9):1001-1009, March 20, 2021.

(Format: HTML, PDF)